02561.HK
VISEN Pharmaceuticals
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 19.68
+2.39%Margins
Gross margin
105.8%
EBITDA margin
9629.1%
EBIT margin
9652.4%
Net margin
—
FCF margin
—
-33.3%
Return on equity
-25.9%
Return on assets
-25.8%
Return on invested capital
-0.00x
Asset turnover
-HKD 521.7M
Cash from operations
HKD 7.11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025